[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100291400":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":28,"centralContacts":33,"locations":43,"responsibleParty":64,"collaborators":66,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":27,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":27,"enrollmentInfo":78,"targetDuration":27,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":27,"overallStatus":45,"whyStopped":27,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Royal North Shore Hospital","OTHER",[8,13,17],{"label":9,"type":6,"description":10,"interventionNames":11},"Group 1","This group of 12 patients will be given 36Gy of Stereotactic Body Radiotherapy (SBRT) divided into six separate doses. This will be delivered two to three time per week.",[12],"Radiation: Stereotactic Body Radiotherapy",{"label":14,"type":6,"description":15,"interventionNames":16},"Group 2","This group (12 patients) will be given 38Gy of Stereotactic Body Radiotherapy (SBRT) divided into six separate doses. This will be delivered two to three time per week.",[12],{"label":18,"type":6,"description":19,"interventionNames":20},"group 3","This group (12 patients) will be given 40Gy of Stereotactic Body Radiotherapy (SBRT) divided into six separate doses. This will be delivered two to three time per week.",[12],[22],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"RADIATION","Stereotactic Body Radiotherapy","Each group will have different dose of stereotactic body radiotherapy (SBRT). Depending on which group patients are in.",[9,14,18],null,[29],{"name":30,"affiliation":31,"role":32},"George Hruby","Northern Sydney Local Health District","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":27,"email":38},"Carolyn Kwong","CONTACT","+61 2 9463 1339","carolyn.kwong@health.nsw.gov.au",{"name":40,"role":36,"phone":41,"phoneExt":27,"email":42},"Heidi Tsang","+61 2 9463 1340","heidi.tsang@health.nsw.gov.au",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","St Leonards","New South Wales","2065","Australia","AU",{"type":52,"coordinates":53},"Point",[54,55],151.19836,-33.82344,{"lat":55,"lon":54},[58,61],{"name":59,"role":36,"phone":60,"phoneExt":27,"email":38},"Carol Kwong, RN","+6129463 1339",{"name":62,"role":36,"phone":63,"phoneExt":27,"email":42},"Clare Banks, RN","+6129463 1340",{"type":65,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR",[67],{"name":68,"class":6},"Northern Sydney and Central Coast Area Health Service","100291400","focal-radiotherapy-for-previously-treated-prostate-cancer-patients-100291400",false,"NCT03073278","Focal Radiotherapy for Previously Treated Prostate Cancer Patients","Phase I Feasibility Trial of Stereotactic Re-irradiation of Prostate Cancer Recurrence Within the Definitively Irradiated Prostate","Inclusion Criteria:\n\n* Men \\> 4yrs from external beam radiotherapy (EBRT) meeting the Phoenix definition of biochemical failure or men \\> 5yrs from EBRT if neo-adjuvant and\u002For adjuvant androgen deprivation therapy (ADT) also used\n* Recurrence localised to less than 1 lobe of prostate on both PMSA and multi-parametric MRI (less than equal to cT2a)\n* Recurrence must be biopsy proven, with positive biopsies limited to the PET and MRI suspicious region.\n* Life expectancy at least 10yrs from time of SBRT\n* PSA \\\u003C 10\n\nExclusion Criteria:\n\n* Recurrence in immediate proximity to rectum (unless able to have hydrogel)\n* Grade 3 or more toxicity from previous EBRT\n* Contra-indicated for fiducial insertion\n* GS 8,9 or 10 disease previously (relative - consider if decent disease free interval)","MALE","18 Years",{"count":79,"type":80},36,"ESTIMATED","INTERVENTIONAL",[83],"NA","To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.",[86],"Locally Recurrent Prostate Cancer","2026-02-04",{"date":89,"type":90},"2026-02-06","ACTUAL",{"date":92,"type":90},"2017-04-24",{"date":94,"type":80},"2027-03-31",{"name":5,"class":6},1]